Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY1R | P25929 | 3/20 | 0.68 |
| ▸ | NPY2R | P49146 | 3/20 | 0.68 |
| ▸ | NPY4R | P50391 | 3/20 | 0.68 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.65 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.65 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.65 |
| ▸ | GHSR | Q92847 | 4/20 | 0.56 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.53 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.53 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.53 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.53 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31593388 | 0.92 | GHSR (0.61) | NPY1RNPY2RNPY4RERAP2ERAP1 | |
| SCHEMBL30772333 | 0.92 | GHSR (0.61) | NPY1RNPY2RNPY4RERAP2ERAP1 | |
| SCHEMBL27164800 | 0.92 | GHSR (0.61) | NPY1RNPY2RNPY4RERAP2ERAP1 | |
| SCHEMBL31593305 | 0.92 | GHSR (0.61) | NPY1RNPY2RNPY4RERAP2ERAP1 | |
| SCHEMBL31468793 | 0.92 | GHSR (0.61) | NPY1RNPY2RNPY4RERAP2ERAP1 | |
| SCHEMBL27204558 | 0.92 | GHSR (0.61) | NPY1RNPY2RNPY4RERAP2ERAP1 | |
| SCHEMBL31468802 | 0.92 | GHSR (0.61) | NPY1RNPY2RNPY4RERAP2ERAP1 | |
| SCHEMBL29578372 | 0.91 | GHSR (0.62) | NPY1RNPY2RNPY4RERAP2ERAP1 | |
| SCHEMBL3384748 | 0.91 | GHSR (0.62) | NPY1RNPY2RNPY4RERAP2ERAP1 | |
| SCHEMBL27702662 | 0.91 | GHSR (0.62) | NPY1RNPY2RNPY4RERAP2ERAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113444183-B | Fusion partners for peptide production | 佩利肯科技控股公司 | 2025-06-17 | — | — | CN | disclosed |
| CN-112088168-B | Chemoselective sulfhydryl coupling with alkene-or alkyne-thiophosphonates and-phosphonates | 柏林合作研究学会 | 2025-02-14 | — | — | CN | disclosed |
| CN-112840027-B | Enzymatic compositions for carbohydrate antigen cleavage, methods, uses, devices and systems related thereto | 不列颠哥伦比亚大学 | 2025-01-10 | — | — | CN | disclosed |
| CN-117545511-A | Thiol coupling with unsaturated phosphorus (V) compounds | 柏林合作研究学会 | 2024-02-09 | — | — | CN | disclosed |
| CN-117295947-A | Multilabelled polymer constructs for detection assays | 剑桥分子诊断有限责任公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-112426438-B | Composition for regulating immune response in acidic environment, preparation method and application thereof | 上海鑫湾生物科技有限公司 | 2023-12-05 | — | — | CN | disclosed |
| CN-109689112-B | Chemoselective coupling of sulfhydryl groups with alkenyl or alkynyl phosphoramides | 柏林合作研究学会 | 2023-10-13 | — | — | CN | disclosed |
| CN-116801892-A | Adipogenic cell compositions and methods | 旗舰创业股份有限公司 | 2023-09-22 | — | — | CN | disclosed |
| CN-113025599-B | Recombinant clostridium histolyticum type I collagenase as well as preparation method and application thereof | 重庆科润生物医药研发有限公司 | 2023-09-12 | — | — | CN | disclosed |
| CN-109071635-B | Contorsbody-single stranded target conjugates | 豪夫迈·罗氏有限公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-116391047-A | Mass spectrometry-based methods and kits for nucleic acid detection and disease diagnosis | YYZ医药科技有限公司 | 2023-07-04 | — | — | CN | disclosed |
| CN-112839512-B | Enzymatic compositions for carbohydrate antigen cleavage on donor organs, methods and uses related thereto | 不列颠哥伦比亚大学 | 2023-06-13 | — | — | CN | disclosed |
| CN-116134151-A | Multiplex analyte detection | 维塔生物科技公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-110256567-B | Method for selecting and generating a customized targeting entity comprising at least two different binding entities and use thereof | 弗·哈夫曼-拉罗切有限公司 | 2023-04-25 | — | — | CN | disclosed |
| CN-115551893-A | Chimeric Antigen Receptors (CAR) targeting natural killer cells | 西雅图儿童医院以西雅图儿童研究机构名义经营 | 2022-12-30 | — | — | CN | disclosed |
| CN-115516104-A | Methods and compositions for sequencing double-stranded nucleic acids | 加利福尼亚太平洋生物科学股份有限公司 | 2022-12-23 | — | — | CN | disclosed |
| CN-115298215-A | Specifically binds to primary immunodeficiency: antibodies to peptides related to viskott-aldrich syndrome and X-linked agammaglobulinemia | 西雅图儿童医院以西雅图儿童研究机构名义经营 | 2022-11-04 | — | — | CN | disclosed |
| CN-114599795-A | Methods and compositions for capping nucleic acids | 加利福尼亚太平洋生物科学股份有限公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-114423861-A | Expression of modified proteins in peroxisomes | 起源生物有限责任公司 | 2022-04-29 | — | — | CN | disclosed |
| CN-114126636-A | Compositions for treating insulin deficiency disorders | 日内瓦大学 | 2022-03-01 | — | — | CN | disclosed |